GREGORY JULIA P 4
4 · Nurix Therapeutics, Inc. · Filed Sep 17, 2025
Insider Transaction Report
Form 4
GREGORY JULIA P
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-17$1.86/sh+10,750$19,995→ 10,750 total - Exercise/Conversion
Director Stock Option (right to buy)
2025-09-17−10,750→ 22,583 totalExercise: $1.86Exp: 2029-12-22→ Common Stock (10,750 underlying)
Footnotes (1)
- [F1]The stock option vested as to 1/48 of the total shares monthly beginning September 12, 2019, and was vested in full on August 12, 2023.